Core Pharmacology and Five Key Benefits 1. Superior Fat Reduction Dual-pathway fat reduction: GLP-1/GIP signaling inhibits the hypothalamic appetite center and delays gastric emptying, leading to naturally reduced food intake; meanwhile, glucagon receptor activation boosts basal metabolic rate and accelerates the oxidative breakdown of visceral and hepatic fat (allowing you to actively burn fat while simultaneously eating less). 2. Clinical Data: In the 48-week trial, the 12mg dosage group achieved an average weight loss of 24.2% of their body weight; over 80 weeks, weight loss could reach a maximum of 28%–30%. The treatment preferentially targets visceral fat. When combined with a high-protein diet and strength training during the fat-loss phase, it maximizes muscle preservation—a performance superior to that of Tirzepatide. 3. Improves Abdominal Obesity & Reduces Waist Circumference: Effectively resolves stubborn fat-loss plateaus. 2. Potent Blood Glucose Control & Improved Insulin Resistance Promotes glucose-dependent insulin secretion and suppresses abnormal hyperglycemic hormones, significantly lowering fasting and postprandial blood glucose levels as well as HbA1c. It improves insulin resistance and helps reverse fatty liver disease (showing marked improvement in Non-Alcoholic Fatty Liver Disease/NAFLD). It is one of the optimal medications for patients with Type 2 Diabetes complicated by obesity ("Diabesity"). 3. Comprehensive Metabolic Optimization Downregulates triglycerides and "bad" cholesterol (LDL), and helps manage hypertension. It also improves severe snoring induced by obesity (Obstructive Sleep Apnea/OSA), leading to significant relief from nocturnal hypoxia and daytime somnolence. 4. Joint Health Improvement (Confirmed by Phase III Clinical Trials) For overweight or obese patients suffering from knee osteoarthritis: Weight loss reduces mechanical load on the joints, while the medication's anti-inflammatory properties provide significant relief from knee pain and mobility limitations. 5. Fitness Applications: Fat Loss & Muscle Building Stack (Pair with KLOW80 as per your price list) Fat Loss Phase (Standard Dosage): Controls appetite and boosts metabolism for rapid fat shedding. Pair with KLOW80 (containing BPC-157, TB-500, GHK-Cu, and KPV) to prevent muscle catabolism and repair training-induced tissue damage, ensuring you lose fat without losing muscle mass. Lean Bulking Phase (Micro-dosing): 0.5–2 mg / Designed for minimal, weekly use, this formula offers mild fat control and inhibits the conversion of excess calories into body fat. It avoids severely suppressing appetite, thereby ensuring adequate caloric and protein intake to support muscle growth—enabling "clean bulking" without gaining unwanted fat. Target Audience (Two Main Categories: Medical Use + Fitness & Fat Loss) ✅ Individuals with Established Medical Indications Adults with Type 2 Diabetes: Those whose blood sugar remains poorly controlled despite diet, exercise, and oral medications; priority is given to those with concurrent overweight or obesity. Individuals with Obesity: BMI ≥ 30 kg/m²; includes cases of simple obesity, those unable to lose weight through diet and exercise alone, and cases of refractory obesity (where previous weight loss attempts using Semaglutide or Tirzepatide yielded unsatisfactory results). Overweight Individuals with Comorbidities: BMI ≥ 27 kg/m²; includes those with any of the following concurrent conditions: hyperlipidemia, hypertension, fatty liver disease, impaired glucose tolerance, sleep apnea, or knee osteoarthritis. Individuals with Excessive Visceral Fat / Abdominal Obesity: Waist circumference ≥ 90 cm for men, ≥ 85 cm for women; includes those with visceral fatty liver or elevated insulin levels. ✅ Fitness & Body Composition Management (Non-Medical Use) Rapid Fat Shredding for Competition Prep: Short-term (4–8 weeks) rapid reduction of body fat to break through weight-loss plateaus (specifically for pre-competition "cutting" in bodybuilding/fitness); best paired with KLOW80 to prevent muscle loss. Individuals Prone to Fat Accumulation During Muscle Gain: Those who tend to gain belly fat whenever they gain weight, or who have poor insulin sensitivity; uses low-dose fat control to achieve "clean bulking" (muscle gain with minimal fat gain). High-BMI Fat Loss: Individuals with a high baseline body weight who are highly prone to binge eating and weight rebound when dieting; utilizes the long-acting appetite-suppressing effects of Reta to reduce binge eating episodes.
